Bionano Genomics Inc (BNGO)
1.15
+0.04
(+3.60%)
USD |
NASDAQ |
May 15, 16:00
1.14
-0.01
(-0.87%)
After-Hours: 20:00
Bionano Genomics Shareholders Equity (Quarterly): 82.77M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 82.77M |
December 31, 2023 | 96.16M |
September 30, 2023 | 119.00M |
June 30, 2023 | 214.76M |
March 31, 2023 | 231.49M |
December 31, 2022 | 249.40M |
September 30, 2022 | 281.74M |
June 30, 2022 | 284.73M |
March 31, 2022 | 311.18M |
December 31, 2021 | 337.12M |
September 30, 2021 | 341.56M |
June 30, 2021 | 345.87M |
March 31, 2021 | 362.72M |
Date | Value |
---|---|
December 31, 2020 | 35.08M |
September 30, 2020 | 14.68M |
June 30, 2020 | 5.837M |
March 31, 2020 | -4.213M |
December 31, 2019 | 3.614M |
September 30, 2019 | -7.378M |
June 30, 2019 | -1.345M |
March 31, 2019 | 5.870M |
December 31, 2018 | 10.14M |
September 30, 2018 | 15.24M |
June 30, 2018 | -57.28M |
March 31, 2018 | -54.02M |
December 31, 2017 | -50.23M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-7.378M
Minimum
Sep 2019
362.72M
Maximum
Mar 2021
165.24M
Average
166.88M
Median
Shareholders Equity (Quarterly) Benchmarks
Bruker Corp | 1.415B |
Azenta Inc | 2.223B |
Harvard Bioscience Inc | 68.81M |
Akoya Biosciences Inc | 53.77M |
Singular Genomics Systems Inc | 179.01M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 158.00M |
Total Liabilities (Quarterly) | 75.22M |
Debt to Equity Ratio | 0.3513 |
Current Ratio | 1.463 |
Net Debt Paydown Yield | -9.11% |